Global Anatomic Pathology Market Booming at high CAGR of 6.35% by 2026
Posted by nileshdbmr on November 28th, 2019
Global Anatomic Pathology Market is expected to rise from its initial estimated value of USD 18.66 billion in 2018 to an estimated value of USD 30.53 billion by 2026, registering a CAGR of 6.35% in the forecast period of 2019-2026. This rise in market value can be attributed to the increasing Incidence of Cancer.
Anatomic pathology is a medical speciality that is required in the diagnosis of disease based on the microscopic, macroscopic, biochemical, immunologic and molecular examination of organs and tissues. In the last few years, surgical pathology has evolved extremely, from an ancient examination of whole bodies (autopsy) to modern techniques needed for the diagnosis and prognosis of cancer to guide treatment decision-making in oncology.
Download PDF Sample report @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-anatomic-pathology-market
Competitive Analysis: Global Anatomic Pathology Market
Global anatomic pathology market is highly fragmented and the major players have used various strategies such as new product launches, expansions, agreements, joint ventures, partnerships, acquisitions, and others to increase their footprints in this market. The report includes market shares of anatomic pathology market for global, Europe, North America, Asia-Pacific, South America and Middle East & Africa.
Key Market Competitors: Global Anatomic Pathology Market
Few of the major competitors currently working in the global anatomic pathology market are F. Hoffmann-La Roche Ltd. (Switzerland), Thermo Fisher Scientific Inc.(U.S.), Koninklijke Philips N.V.( Netherlands), Leica Microsystems(Germany), Digipath, Inc.(U.S.), Laboratory Corporation of America Holdings (U.S.), Danaher(U.S.)., Angsana Molecular & Diagnostics Laboratory Pte Ltd. (Singapore), Quest Diagnostics Incorporated.(U.S.), Agilent Technologies, Inc (U.S.), Sakura Tech (Singapore), BioGenex, Bio SB (U.S.), NeoGenomics Laboratories, Inc.(U.S.), Nikon Corporation(Japan), PerkinElmer, Inc.(U.S.), Definiens (Germany), Boston Scientific Corporation(U.S.), Advanced Cell Diagnostics, Inc.(U.S.), Tecan Trading AG(Switzerland), RareCyte, Inc.(U.S.), Oxford Cancer Biomarkers Ltd. (U.K.), Enzo Biochem Inc. (U.S.), and Epic Sciences (U.S.) among others.
Segmentation: Global Anatomic Pathology Market
Reasons to Purchase this Report:
Customization of the Report:
Data Bridge Market Research set forth itself as an unconventional and neoteric Market research and consulting firm with unparalleled level of resilience and integrated approaches. We are determined to unearth the best market opportunities and foster efficient information for your business to thrive in the market.
Data Bridge Market Research
Like it? Share it!
About the Authornileshdbmr
Joined: September 27th, 2019
Articles Posted: 235
More by this author